Quality indicator for CR billing helps keep compliance on track

March 2009
Clinical Trials Administrator;Mar2009, Vol. 7 Issue 3, p30
This article reports on the use of a quality indicator in clinical research billing by the M.D. Anderson Cancer Center Orlando in Orlando, Florida. The Center used this in response to the increase in people enrolled in its clinical trials. According to Allisun Feazell, manager of the office of protocol regulations at the Center, between 2005 and 2008, they have increased patients from 64 to 117 and also increased their sponsored studies. The use of quality indicator helps the Center to have a quick look at its level of billing compliance.


Related Articles

  • Puerto Rican Government Offers Support for Country's Cancer Center. Brower, Vicki // JNCI: Journal of the National Cancer Institute;6/16/2004, Vol. 96 Issue 12, p901 

    Reports on the funds given by the government for its cancer research center in Puerto Rico. Development of a cancer research hospital; Impact of the center on the care of cancer patients; Lack of clinical trials available to patients.

  • Evaluation of a complex intervention to improve activities of daily living of disabled cancer patients: protocol for a randomised controlled study and feasibility of recruitment and intervention. Lindahl-Jacobsen, Line; Hansen, Dorte Gils√•; Cour, Karen la; S√łndergaard, Jens // BMC Health Services Research;2014, Vol. 14 Issue 1, p1 

    Background Many cancer patients have problems performing activities of daily living (ADL). A randomised controlled trial was designed to examine the effects of an ADL intervention in addition to standard treatment and care in a hospital setting. The objective of this article was to present the...

  • LABORATORIES.  // Applied Clinical Trials;Aug2011 Supplement, p69 

    The article lists several medical research laboratories worldwide including Advanced Technology Corp., Esoterix Clinical Trials Services, and Simbec Research Ltd.

  • Central.  // Applied Clinical Trials;Aug2011 Supplement, p74 

    The article lists several central research institutes worldwide including Aushon Biosystems, CEMO SA, and Labconnect LLC.

  • At-Home Study Services.  // Applied Clinical Trials;Aug2011 Supplement, p90 

    The article lists several at-home study service providers worldwide including Globalcare Clinical Trials, Amarex Clinical Research, and Biomedical Systems.

  • Clinical Trial watch.  // Urology Times;3/1/2006, Vol. 34 Issue 3, p26 

    A list of several National Cancer Institute trials in the U.S. is presented including Phase III of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoletic Cell Transplantation, Phase I/II Study of Temozolomide in Children With Newly Diagnosed...

  • Sorafenib enhances HRQOL in renal cancer.  // PharmacoEconomics & Outcomes News;7/28/2007, Issue 533, p1 

    The article reports the results of a phase III study on sorafenib treatment. The study claims that sorafenib treatment improves some symptoms and enhances health-related (HR) QOL among renal cancer patients. The study included 903 patients with unresectable and/or metastatic renal cancer. The...

  • Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. Madsen, S. M.; Holm, S.; Riis, P. // Journal of Medical Ethics;Apr2007, Vol. 33 Issue 4, p234 

    The attitudes of women patients with cancer were explored when they were invited to participate in one of three randomised trials that included chemotherapy at two university centres and a satellite centre. Fourteen patients participating in and 15 patients declining trials were interviewed....

  • CLINICAL TRIAL FLOW DIAGRAMS: A "SNAP-SHOT" APPROACH TO CLINICAL TRIALS. Carney, Pam; Knoop, Teresa; Cherry, Gloria; Whitlock, James; Leiserson, Anna Belle // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p456 

    Less than 3% of adult cancer patients enroll in clinical trials. However, it is estimated that 12%-44% would be eligible to participate. Many barriers to clinical trial participation have been identified including lack of information or misinformation about access and eligibility. The oncology...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics